Comparison of melatonin with growth factors in promoting precursor cells proliferation in adult mouse subventricular zone by Sotthibundhu, Areechun et al.
EXCLI Journal 2016;15:829-841 – ISSN 1611-2156 
Received: August 26, 2016, accepted: November 21, 2016, published: December 21, 2016 
 
 
829 
Original article: 
COMPARISON OF MELATONIN WITH GROWTH FACTORS IN 
PROMOTING PRECURSOR CELLS PROLIFERATION IN ADULT 
MOUSE SUBVENTRICULAR ZONE 
 
Areechun Sotthibundhua,b, Kasima Ekthuwapraneec,d, Piyarat Govitraponga,d,e* 
 
a  Center for Neuroscience, Faculty of Science, Mahidol University, Bangkok, Thailand 
b  Chulabhorn International College of Medicine, Thammasat University, Patumthani,  
12120, Thailand 
c  Physical therapy, Srinakharinwirot University, Ongkharak, Nakhonnayok 26120, Thailand 
d  Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, 
Salaya, Nakornpathom, Thailand 
e Chulabhorn Graduate Institute, Kamphaeng Phet 6 Road, Lak Si, Bangkok 10210,  
Thailand 
 
* Corresponding author: Piyarat Govitrapong, Chulabhorn Graduate Institute, Kamphaeng 
Phet 6 Road, Lak Si, Bangkok 10210, Thailand, Tel, Fax: (662)554-1900 ext. 2641;  
E-mail: piyarat.gov@mahidol.ac.th 
 
 
http://dx.doi.org/10.17179/excli2016-606 
 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/). 
 
ABSTRACT 
Melatonin, secreted mainly by the pineal gland, plays roles in various physiological functions including protect-
ing cell death. We showed in previous study that the proliferation and differentiation of precursor cells from the 
adult mouse subventricular zone (SVZ) can be modulated by melatonin via the MT1 melatonin receptor. Since 
melatonin and epidermal growth factor receptor (EGFR) share some signaling pathway components, we investi-
gated whether melatonin can promote the proliferation of precursor cells from the adult mouse SVZ via the ex-
tracellular signal-regulated protein kinase /mitogen-activated protein kinase (ERK/MAPK) pathways in compari-
son with epidermal growth factor (EGF). Melatonin-induced ERK/MAPK pathways compared with EGF were 
measured by using in vitro and vivo models. We used neurosphere proliferation assay, immunocytochemistry, 
and immuno-blotting to analyze significant differences between melatonin and growth factor treatment. We also 
used specific antagonist and inhibitors to confirm the exactly signaling pathway including luzindole and U0126. 
We found that significant increase in proliferation was observed when two growth factors (EGF+bFGF) and 
melatonin were used simultaneously compared with EGF + bFGF or compared with melatonin alone. In addi-
tion, the present result suggested the synergistic effect occurred of melatonin and growth factors on the activat-
ing the ERK/MAPK pathway. This study exhibited that melatonin could act as a trophic factor, increasing prolif-
eration in precursor cells mediated through the melatonin receptor coupled to ERK/MAPK signaling pathways. 
Understanding the mechanism by which melatonin regulates precursor cells may conduct to the development of 
novel strategies for neurodegenerative disease therapy. 
 
Keywords: epidermal growth factor, extracellular signal-regulated protein kinase, melatonin, mitogen-activated 
protein kinase, neural stem cells, subventricular zone 
 
Abbreviations: BDNF: brain-derived neurotrophic factor; bFGF: basic fibroblast growth factor; EGF: epidermal 
growth factor; EGFR: epidermal growth factor receptor; ERK: extracellular signal-regulated kinase; MT: mela-
tonin receptor; PKA: protein kinase A; PKC: protein kinase C; PLC: phospholipase C; MAP: mitogen-activated 
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protein; MAPK: mitogen-activated protein kinase; NAS: N-acetyl serotonin; SGZ: subgranular zone; SVZ: sub-
ventricular zone 
 
 
 
INTRODUCTION 
Two active areas of adult brain which 
still have cell proliferation and differentia-
tion are the subgranular zone (SGZ) in the 
dentate gyrus of the hippocampus  and the 
anterior part of the subventricular zone 
(SVZ) lining the lateral ventricle (Altman 
and Das, 1965; Altman, 1969). The prolif-
eration and differentiation of adult precursor 
cells are modulated by several molecules, 
such as growth factors and hormones, under 
physiological and pathological conditions 
(Lledo et al., 2006). Precursor cells obtained 
from the adult SVZ and cultured in epider-
mal growth factor (EGF)-containing medium 
grow to form neurospheres that are self-
renewing and multipotent (Ayuso-Sacido et 
al., 2010; Doetsch et al., 2002; Shi et al., 
2008). EGF was discovered by Cohen and 
Elliott (1989). Subsequent studies demon-
strated that EGF is a usual mitogenic factor 
that stimulates the generation of different 
types of cells such as fibroblasts and epithe-
lial cells (Cohen and Elliott, 1963). Progeni-
tor cells in both the embryonic and postnatal 
SVZ divide in response to EGF ligand and 
EGF receptor (EGFR) expression, and they 
retain the ability to differentiate into neurons 
and glial cells (Gritti et al., 1999; Reynolds 
et al., 1992; Weickert et al., 2000). EGFR 
signaling influences vary cellular mecha-
nisms involved in neurogenesis, including 
neural cell survival, proliferation, differentia-
tion and migration, by activating the mito-
gen-activated protein (MAP) kinase (MAPK) 
signaling cascade via the extracellular signal-
regulated kinase (ERK1/2) (Carreira et al., 
2010; Shi et al., 2008).  
Melatonin (5-methoxy-N-acetyltrypta-
mine) secreted mainly by the pineal gland, 
controls several physiological functions 
(Stehle et al., 2011). Melatonin as well as its 
metabolites plays anti-apoptotic free radical-
scavenging properties (Hardeland et al., 
2012). The intermediate precursor of mela-
tonin, N-acetyl serotonin (NAS), enhanced 
proliferation and differentiation in hippo-
campal cells through brain-derived neu-
rotrophic factor (BDNF) receptor TrkB (Jang 
et al., 2010; Sompol et al., 2011; Tosini et 
al., 2012; Yoo et al., 2011). Extending 
demonstration also suggests that melatonin 
might be an attractive agent in the neurogen-
esis context. Melatonin enhanced neurogene-
sis in embryos (Kong et al., 2008; Moriya et 
al., 2007). Our previous study showed that 
melatonin facilitated proliferation in precur-
sor cells from the adult mouse SVZ and the 
adult rat SGZ via the melatonin receptor 
(MT1) (Sotthibundhu et al., 2010; Tocharus 
et al., 2014). Consistent with this view, neu-
ritogenesis and differentiation in neuroblas-
toma cells can be influenced by melatonin in 
vitro through a mechanism that involves the 
activation of ERK via the MT1 receptor 
(Witt-Enderby et al., 2000). Melatonin pro-
moted human mesenchymal stem cell differ-
entiation into osteoblasts through the for-
mation of MT2/MEK/ERK1/2 complexes, 
causing osteogenic gene expression (Radio 
et al., 2006; Sethi et al., 2010).  
Since melatonin and EGF share some 
similar effects, we compared the prolifera-
tive effect and the signaling transductions of 
melatonin and EGF in the adult mouse SVZ 
precursor cells by using in vitro and in vivo 
model studies.  
 
MATERIALS AND METHODS 
Drug administration 
Sixteen male 8-week-old C57BL6 mice 
were purchased from the National Experi-
mental Animals Center of Mahidol Universi-
ty, Salaya Campus, Thailand. The experi-
ment procedures conformed under ethical 
guideline for animal research which is ap-
proved by the Mahidol University Animal 
Care and Use Committee (MU-ACUC). 
Drug administration was performed accord-
ing to our previously described protocol 
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(Mukda et al., 2009). Briefly, at eight weeks, 
C57BL6 mice were randomly appointed to 
either saline or melatonin groups. Each 
group comprised of 8 mice. The animals 
were injected subcutaneously with saline or 
melatonin (5 mg/kg body weight; M5250, 
Sigma–Aldrich, St. Louis, MO, USA) once 
daily (at 10:00 a.m. to obviate endogenous 
outcome of melatonin) for 7 consecutive 
days. In our previous study, 5 mg/kg body 
weight melatonin was the minimal effective 
dose (Mukda et al., 2009). Melatonin is very 
low at 10 a.m., therefore this time point is 
suitable to detect any change. The C57BL6 
mouse is a proper stain to study the role of 
exogenous melatonin on the progenitor cell 
proliferation. This stain expresses both MT1 
and MT2 melatonin receptors, although it 
synthesizes low level of melatonin compared 
with other stains of mice (Dubocovich et al., 
2005; Roseboom et al., 1998). In this case, 
the existing melatonin receptor may become 
supersensitive thus this makes this animal 
species suitable for studying its activity. An-
imals were sacrificed 24 hrs after the last 
treatment. Brains were immediately removed 
and dissected. The SVZ was dissected for 
Western blot analysis. 
 
Neurosphere proliferation assay 
Adult neural precursors were obtained 
from the adult mouse SVZ and cultured as 
floating aggregates (neurospheres), as previ-
ously described (Sotthibundhu et al., 2010). 
Briefly, SVZ tissue was dissociated in 
0.05 % trypsin (25300-054, Invitrogen, San 
Diego, CA, USA), plated in 24-well plates at 
a density of 1800 cells per well or plated in 
T25 flasks at a density of 0.5x104 cells/ml. 
The cells were cultured at 37 °C in 5 % CO2 
for 7 days in serum-free neurosphere medi-
um containing NeuroCult (05701, Stem Cell 
Technologies, Vancouver, Canada) with or 
without 10 ng/ml bFGF (11123149001, 
Roche, Mannheim, Germany) and 20 ng/ml 
EGF (356052, BD Biosciences, Franklin, NJ, 
USA). Melatonin (100 µM melatonin dis-
solved in 40 % ethanol for 1 µM melatonin 
as a final concentration) was added to SVZ 
cultures at day 0. In some experiments, SVZ 
cultures were also treated with either luz-
indole (L2407, Sigma–Aldrich; 100 µM luz-
indole dissolved in DMSO for a final con-
centration as 1 µM luzindole) or U0126 
(U120, Sigma–Aldrich; 23.5 µM U0126 dis-
solved in DMSO for a final concentration of 
1 µM U0126). At the end of the 7-day prolif-
eration period, the size and number of neuro-
spheres per well was defined. 
 
Immunocytochemistry and quantitative 
immunofluorescence determination  
The effect melatonin on the expression of 
nestin was investigated by transferring neu-
rospheres to cover slip coated with poly-L-
ornithine (P4957, Sigma–Aldrich) and lam-
inin (CC095, Millipore, Bedford, MA, 
USA). After 1 day of incubation in 37 °C, 
neurospheres were fixed with 4 % paraform-
aldehyde for 20 min at room temperature and 
washed with PBS 3 times before permea-
bilized using 1 % Triton X-100 for 10 min. 
Non-specific binding was blocked with 5 % 
normal goat serum in PBS containing 1 % 
Trion X for 10 min before incubating with 
the mouse monoclonal antibody against nes-
tin (1:200, MB353, Millipore) and rabbit 
polyclonal antibody against Ki67 (1:200, 
AB9260, Millipore) overnight at 4 °C. The 
coverslips were washed three times with 
PBS and incubated with Alexa Fluor® 488 
Goat Anti-Rabbit IgG (1:2000, ab150077, 
Abcam, Cambridge, MA, USA), Alexa Flu-
or® 568 Goat Anti-Mouse IgG fluorescent 
dye (1:2000, ab175473, Abcam), and DAPI 
nuclear stain from Invitrogen (1:2000, 
62248, Invitrogen) for 2 hrs at room temper-
ature. The coverslips were mounted with an-
tifade reagent (H1000, Vectashield, Vector 
Laboratories, Burlingame, CA, USA) after 
washing with PBS. The immunoreactivity 
was visualized using a confocal laser scan-
ning microscope (Olympus Fluoview FV10i, 
Tokyo, Japan). 
To quantify the intensity of Ki67 and 
DAPI staining, images were captured at 10x 
or 60x magnification from at least five ran-
domly selected fields for each of four inde-
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pendent experiments. ImageJ software (NIH) 
was used to compute the fluorescence inten-
sity. 
 
Western blot analysis 
Following experimental treatments, the 
cell pellet and SVZ tissue were resuspended 
in lysis buffer with 1 % protease inhibitor 
and 1 % phosphatase inhibitor and sonicated 
for 10 s twice. Lysate was then centrifuged 
at 12,000 × g for 15 min at 4 °C, and the su-
pernatant was used for western blot pro-
cessing. After the protein concentration was 
determined by the method described by 
Lowry et al. (1951), the samples were dena-
tured in sample buffer at 95 °C for 5 min. 
Protein was loaded onto a 10-12 % SDS–
PAGE gel and then electrophoretically trans-
ferred to a polyvinylidenedifluoride (PVDF) 
membrane (Amersham Biosciences, Pisca-
taway, NJ, USA). The transfer efficiency 
was checked by Ponceau-S red staining (Bio-
Rad Laboratories, Hercules, CA, USA). The 
membranes were washed with Tris-buffered 
saline containing 0.1 % Tween-20 (TBST) 
for 5 min, incubated in blocking buffer for 
1 hr at room temperature and then incubated 
overnight at 4°C with rabbit polyclonal anti-
body against c-Raf (1:1,000, 9422, Cell Sig-
naling, Danvers, MA, USA), rabbit polyclo-
nal antibody against p-c-Raf (1:1,000, 9427, 
Cell Signaling), mouse monoclonal antibody 
against ERK1/2 (1:5,000, SC514302, Santa 
Cruz, CA, USA), mouse monoclonal anti-
body against p-ERK1/2 (1:5,000, SC81492, 
Santa Cruz), rabbit polyclonal antibody 
against c-Myc (1:1,000, SC40, Santa Cruz) 
or rabbit polyclonal antibody against p-c-
Myc (1:1,000, SC8000-R, Santa Cruz). The 
membranes were washed three times for 5 
min each with TBST, incubated in HRP-
conjugated anti-mouse IgG antibody 
(1:10,000, 7076, Cell Signaling) or anti-
rabbit IgG antibody (1:10,000, 7074, Cell 
Signaling) for 1 hr at room temperature and 
washed in TBST. Finally, the membranes 
were visualized by enhanced chemilumines-
cence using ECLTM Prime (RPN2232, Amer-
sham Biosciences) and the membrane was 
exposed on X-ray film (Kodak, Rochester, 
NY, USA). The immunoblot band densities 
were normalized with its unphosphorylated 
protein and quantified using a densitometer 
in the Scion image analysis program (Na-
tional Institutes of Health, Bethesda, MD, 
USA). 
 
Data analysis and statistical methods 
The data from all experiments were ex-
pressed as the mean ± S.E.M. and compared 
using a one-way analysis of variance 
(ANOVA) followed by the Tukey–Kramer 
test or the independent samples t-test using 
GraphPad Prism version 5. Significance was 
assumed when P-values were less than 0.05. 
 
RESULTS 
Effect of melatonin on nestin and Ki-67 
immunoreactivity 
In order to demonstrate that melatonin is 
able to increase the proliferation of the pro-
genitor cells derived from adult subventricu-
lar zone, the neurospheres were stained using 
immunocytochemistry method with Ki-67, a 
proliferating maker (green) and nestin, a 
multipotential neural stem cell marker (red). 
The results (Figure 1A, C) showed that neu-
rospheres in the proliferative condition re-
vealed positive signal of proliferating mark-
er, Ki-67. The results also indicated that in 
the cluster of same neurospheres co-localized 
with nestin protein as shown by red color 
around the spheres. Ki-67 antigen is ex-
pressed during active phase of the cell cycle, 
whereas the resting phase lacks Ki-67 ex-
pression (Kee et al., 2002). While bromode-
oxyuridine (BrdU) is expressed during only 
DNA replication, which could be happened 
in DNA damage and repair processes, Ki-67 
is considered as a suitable marker for study 
cells in proliferation state. In this study, Ki67 
expression was used to detect alterations in 
proliferation. As shown in Figure 1B, mela-
tonin increased the ratio of Ki67/DAPI to 
155.0 ± 4.4 % of the control treatment (P < 
0.01). The result revealed that melatonin 
treatment increased the expression of Ki-67 
and nestin when compared to control. This 
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result indicated that 1 µM melatonin in-
creased cell proliferation as well as the im-
mature neurons.  
 
 
Figure 1: The neurosphere staining with anti-
Ki67 (green) and anti-nestin (red) antibodies. 
Progenitor cells derived from adult SVZ were cul-
tured in the medium containing growth factor in 
the absence  and presence of 1 µM melatonin. 
Neurospheres were stained with anti-Ki67 and 
DAPI (A), and with anti-nestin antibodies (C). (B) 
For quantitative immunofluorescence analysis of 
Ki-67/DAPI-positive cells, images were captured 
from at least five randomly selected fields and 
were analyzed using ImageJ software. T-test 
was performed for statistical analysis (** denote 
a significant difference at P < 0.01 compared to 
the control group. The results were expressed as 
mean ± S.E.M of four independent experiments 
and scale bar = 50 (A-F) and 100 µm (G-L). 
 
Comparing melatonin with other trophic 
factors (EGF, bFGF) in promoting  
precursor cell proliferation  
To test whether melatonin can act as 
trophic factor similar to EGF, neurosphere 
cultures were established with cells isolated 
from adult mice SVZ area and cultured in the 
presence or absence of the growth factors. 
After 7 days of precursor proliferation peri-
od, the total number of neurospheres in each 
culture was counted. The number of neuro-
spheres generated in medium without growth 
factor (control) was 6.7 ± 0.5 numbers/well 
(Figure 2). The number of neurospheres gen-
erated in cultured condition carrying 
20 ng/ml EGF, EGF plus 10 ng/ml bFGF, 
1 µM melatonin, or melatonin plus EGF and 
bFGF significantly increased, compared with 
the control without growth factors (Figure 
2). No difference in numbers of spheres was 
found between EGF versus EGF plus bFGF 
groups. This result was supported from 
Moriya et al. (2007) which showed the pro-
liferation of neural stem cells completely de-
pends on EGF. Melatonin alone significantly 
increased the formation of neurosphere when 
compared with EGF plus bFGF. A signifi-
cant increase in proliferation was observed 
when two growth factors and melatonin were 
used simultaneously compared with EGF 
plus bFGF (p < 0.01) or melatonin alone (p < 
0.01). This suggested the synergistic effect 
occurred. 
 
Melatonin increases precursor cell prolifer-
ation via the ERK/MAPK pathway 
Because the main proliferative pathway 
of precursor cells is triggered by the activa-
tion of EGFR through the ERK/MAPK sig-
naling cascade with the subsequent activa-
tion involved with cell cycle modulation 
both transcription factors and modification 
of proteins, we hypothesized that melatonin 
treatment may act via the ERK/MAPK 
pathway. Therefore, we investigated the ex-
pression of signaling molecules in neuro-
spheres derived from the adult mouse SVZ 
and treated with growth factors and/or mela-
tonin using Western blot analysis. Exper-
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Figure 2: The proliferative effect of growth 
factors and melatonin on the adult mouse 
SVZ precursor cells. The numbers of neuro-
spheres per well generated from freshly dissoci-
ated SVZ cells plated in the medium in the pres-
ence or absence of 20 ng/ml EGF, 10 ng/ml 
bFGF, and 1 µM melatonin are shown. The neu-
rospheres were formed after culture for 7 days. 
ANOVA was performed for statistical analysis (** 
and *** denote statistical significance at P < 0.01 
and < 0.001, respectively, compared with the 
control without growth factors, # denotes statisti-
cal significance at P < 0.05 compared between 
melatonin alone versus the combination of two 
growth factors, and statistical significance at P < 
0.05 compared between the combination of two 
growth factors plus melatonin versus the combi-
nation of two growth factors, & denotes statistical 
significance at P < 0.05 compared between mel-
atonin alone versus the combination of two 
growth factors plus melatonin). The results are 
expressed as mean ± S.E.M. of four independent 
experiments. 
 
iments in which EGF and melatonin were 
added separately in vitro (Figure 3). The re-
sult showed that melatonin significantly in-
creased the phosphorylation of c-Raf, 
ERK1/2 and c-Myc and EGF significantly 
increased phosphorylation of c-Raf, ERK1/2 
and c-Myc when compared with control. 
Two growth factors plus melatonin signifi-
cantly increased c-Raf, ERK1/2 and c-Myc 
when compared with EGF + bFGF. The ef-
fects of the combination of melatonin plus 
two growth factors were higher than those 
effects from growth factor combination. The 
present result suggested the synergistic effect 
of melatonin and growth factors on activat-
ing the ERK/MAPK pathway.  
 
Figure 3: The effect of growth factors and 
melatonin on signaling protein expressions. 
Neurospheres were derived from the adult 
mouse SVZ and cultured in the presence or ab-
sence of 20 ng/ml EGF, 10 ng/ml bFGF, and 
1 µM melatonin. The levels of p-c-Raf, pERK1/2 
and p-c-Myc were normalized with c-Raf, 
ERK1/2 and c-Myc, respectively, and quantified 
using densitometry. ANOVA was performed for 
statistical analysis and values are expressed as 
mean ± S.E.M. of four independent experiments 
(*, ** and *** denote statistical significance at P < 
0.05, < 0.01 and < 0.001, respectively, compared 
with the control, # denotes statistical significance 
at P < 0.05 compared between two growth fac-
tors versus the combination of melatonin plus 
two growth factors). 
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In addition, we carried out the in vivo exper-
iment, melatonin was injected subcutaneous-
ly (Figure 4). The in vivo study also showed 
that melatonin was able to increase the p-
cRaf, p-ERK1/2 and p-c-Myc when com-
pared with the control group.  
 
The effect of luzindole, an antagonist of 
melatonin receptor and U0126, a MEK1/2 
inhibitor, on the proliferative effect of 
melatonin  
ERK/MAPK signaling pathways are up-
regulated upon the activation of various 
types of receptors (Balmanno and Cook, 
2009; Roudabush et al., 2000; Wells, 1999). 
We examined the involvement of melatonin 
receptors in the melatonin-induced activation 
of the ERK/MAPK signaling pathway 
whether this signaling pathway underlies the 
proliferative consequence of melatonin on 
precursor cells from the adult mouse. The to-
tal of neurospheres isolated from the SVZ 
incubated in medium without melatonin 
(control) was 13.6 ± 1.1 numbers/well. One 
micromolar melatonin significantly extended 
the total of neurospheres. When applied 
alone, 1 µM luzindole or 1 µM U0126 had 
no significant effect on cell proliferation. 
Pre-incubation with 1 µM luzindole prior to 
melatonin, the proliferative effect of melato-
nin was abolished, and pre-incubation with 
1 µM U0126 prior to melatonin significantly 
abolished the melatonin effects (Figure 5). 
The results indicated that melatonin pro-
motes cell proliferation via melatonin recep-
tor through ERK/MAPK pathway. 
Western blot analysis (Figure 6) showed 
that c-Raf, ERK and c-Myc phosphorylation 
increased significantly following the admin-
istration of 1 µM melatonin, compared with 
the untreated control group. This activation 
significantly decreased by pre-incubation 
with 1 µM luzindole or 1 µM U0126 com-
pared to untreated cell. The present data fur-
ther indicated that the ERK/MAPK pathway 
is the possible pathway which regulated SVZ 
precursor proliferation by melatonin through 
the melatonin receptor.  
 
 
Figure 4: The effect of melatonin on signaling 
protein expressions in vivo. Animals were 
treated with saline or melatonin for 7 consecutive 
days. The levels of p-c-Raf, pERK1/2 and p-c-
Myc were normalized with c-Raf, ERK1/2 and c-
Myc, respectively, and quantified using densi-
tometry. ANOVA was performed for statistical 
analysis and values are expressed as mean ± 
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S.E.M. from 4 mice per group (* denotes statisti-
cal significance at P < 0.05, compared with the 
control). 
 
 
Figure 5: The effect of luzindole, an antago-
nist of melatonin receptor and U0126, a 
MEK1/2 selective inhibitor, on the melatonin-
induced increase in the proliferation of pre-
cursor cells from the SVZ. Neurospheres were 
generated from freshly dissociated SVZ cells 
plated in medium containing growth factors in the 
presence of 1 µM melatonin, 1 µM luzindole 
and/or 1 µM U0126, as indicated. ANOVA was 
performed for statistical analysis and the results 
are expressed as mean ± S.E.M. of four inde-
pendent experiments (* denotes statistical signif-
icance at P < 0.001 compared with the control; 
## and ### denote statistical significance at P < 
0.01 and < 0.001, respectively, compared with 
melatonin-treated cells). 
 
 
DISCUSSION 
In this examination, we revealed that 
melatonin could perform as a trophic factor, 
like EGF or bFGF, to promote adult neural 
precursor cell proliferation. Although mela-
tonin can enhance neurogenesis in embryos 
and adults (Kong et al., 2008; Moriya et al., 
2007; Sotthibundhu et al., 2010), the precise 
subsequence, by which melatonin up-
regulates cell proliferation, is not fully un-
derstood. For further better understanding 
the pleiotropic function of melatonin, its ef-
fects and modes of action are examined at 
cellular and sub-cellular levels.  
Figure 6: The effect of luzindole, an antago-
nist of melatonin receptor and U0126, a 
MEK1/2 selective inhibitor, on the melatonin-
induced increase in signaling protein expres-
sion. The levels of p-c-Raf, pERK1/2 and p-c-
Myc were normalized with c-Raf, ERK1/2 and c-
Myc, respectively and quantified using densito-
metry. ANOVA was performed for statistical 
analysis and the results are expressed as mean 
± S.E.M. of four independent experiments (** de-
notes statistical significance at P < 0.01 com-
pared with the control; ## and ### denote statis-
tical significance at P < 0.01 and < 0.001, re-
spectively, compared with melatonin-treated 
cells). 
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The second messenger cascades that are 
stimulated by MT1 and MT2 receptors seem 
to differ in a cell-, tissue- and species-
specific manner. The possible cell signaling 
pathways downstream of the MT receptors 
include the Rafs/MEK1/2/ERK1/2 pathway, 
which is stimulated by several mechanisms 
(Kilic et al., 2005; Luchetti et al., 2009; 
Radio et al., 2006; Witt-Enderby et al., 
2000). In particular, our in vitro and in vivo 
studies show that the proliferative outcome 
of melatonin is occurred via the activation of 
the ERK/MAPK pathway. As a blotting re-
sult, melatonin markedly increases the phos-
phorylation of c-Raf, ERK1/2 and c-Myc, re-
spectively. The MT1 receptor can also acti-
vate PLC in the presence of an enlargement 
in intracellular calcium, resulting in phos-
phoinositide hydrolysis and the subsequent 
stimulation of PKC activity (Baba et al., 
2013; Chan and Wong, 2013; von Gall et al., 
2002). ERK/MAPK signaling pathways are 
up-regulated upon the activation of various 
types of receptors (Balmanno and Cook, 
2009; Chan and Wong, 2013; Roudabush et 
al., 2000; Wells, 1999). We examined the 
involvement of melatonin receptors in the 
melatonin-induced activation of the 
ERK/MAPK signaling pathway whether this 
signaling pathway underlies the proliferative 
effect of melatonin on precursor cells from 
the adult mouse.  
Growth factor signaling is important in 
stem cell maintenance and function, and typ-
ical growth factor pathways utilize receptor 
tyrosine kinase signaling. EGF can stimulate 
neural stem cells to self-renew and prolifer-
ate in response EGFR (Doetsch et al., 2002; 
Shi et al., 2008) via the stimulation of the 
MAPK signaling cascade. In this study, we 
have shown similar numbers of spheres 
forming in the EGF and EGF plus bFGF 
groups. This result was sustained from a pre-
vious study which showed that the main 
growth factor affecting neural stem cell pro-
liferation is EGF (Moriya et al., 2007). Sig-
nificant increase in proliferation was ob-
served when two growth factors 
(EGF+bFGF) and melatonin were used sim-
ultaneously compared with EGF+bFGF or 
compared with melatonin alone. This sug-
gested the synergistic effect occurred. In ad-
dition, the present result also suggested the 
synergistic effect of melatonin and growth 
factors on the activating the ERK/MAPK 
pathway. 
Upon activation, ERK1/2 is translocated 
to the nucleus and phosphorylate multiplex 
transcription factors that must be modulated 
in response to growth factors to control cell 
cycle progression, proliferation, survival, 
and the down-regulation of antiproliferative 
genes (Johnson and Lapadat, 2002; Junttila 
et al., 2008; Meloche and Pouyssegur, 2007). 
In addition, activated-ERK1/2 also enhances 
c-Myc protein stability and plays a principle 
role in controlling cell cycle progression and 
apoptosis by driving cells from G0 to late G1 
phase (Pelengaris et al., 2002; Sears et al., 
2000). Although the cell cycle molecules 
modulated by melatonin remain to be illus-
trated, it has been stated that melatonin in-
creases G0/G1 to G2+M cells distribution in 
epithelial cells (Li et al., 1999) and cyclin A 
protein expression in breast cancer cells 
(Margheri et al., 2012). However, melatonin 
affects the cell cycle presumably occurring 
by different doses, duration and related to the 
cell line-specific pattern. 
Blocking MEK1/2 with low concentra-
tion of antagonist U0126 completely abol-
ished melatonin-induced ERK1/2 phos-
phorylation in the adult mouse SVZ precur-
sor cells, demonstrating that melatonin acts 
upstream of ERK1/2 to trigger proliferative 
signaling. As our results, treatment with low 
concentration of U0126 alone did not have 
any effect on the control levels of the pro-
posed activities. ERK/MAPK signaling can 
be induced by various molecules, one of 
which is EGF, which is the main growth fac-
tor typically used in culture media. In addi-
tion, U0126 has been shown not only sup-
presses MEK1/2 activity, but also indirectly 
elevates PI3K (Benz et al., 2010; Hayashi et 
al., 2008). In this respect, ERK/MAPK and 
PI3K signaling have separated roles at dif-
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ferent times in G2/M cell cycle progression 
(Roberts et al., 2002). 
Interestingly, melatonin and MT1 ex-
pression were detected in the developing 
brain (Jimenez-Jorge et al., 2007). This find-
ing suggests that melatonin could perform as 
a protective mechanism against free radical 
damage and could exert some trophic activi-
ties. In addition, the expression of MT1 re-
ceptors during normal brain development in-
dicates that brain melatonin could function 
along this period. Melatonin has recently 
been found as a trophic factor in chick brain 
development, during which it stimulates mi-
totic activity in diencephalic astrocytes 
(Paulose et al., 2009). Melatonin treatment 
can also increase the total of cells with neu-
rite processes in N1E-115 cells, SK-N-SH 
cells and CHO cells (Benitez-King et al., 
1990; Cos et al., 1996; Witt-Enderby et al., 
2000), and this effect occurred via the MT1 
receptor by activation of phosphorylation of 
ERK1/2 (Witt-Enderby et al., 2000).  
Our prior study (Sotthibundhu et al., 
2010) showed that the precursor cells ob-
tained from the adult mouse SVZ expressed 
the MT1 receptor and the proliferative effect 
of melatonin was antagonized by luzindole 
and prevented by pretreatment with pertussis 
toxin (PTX). The instant study presented that 
the stimulatory effect of melatonin on neural 
stem cell proliferation via melatonin receptor 
through ERK1/2 activation were further sup-
ported by the results showing that luzindole 
treatment abolished the increase of p-
ERK1/2 caused by melatonin. We showed 
here that melatonin treatment induced the 
up-regulation of p-c-Raf, p-ERK1/2 and p-c-
Myc in differentiated neural stem cells com-
pared with control group both in vitro and in 
vivo models. 
A pharmacological of melatonin receptor 
blockage or the ERK1/2 signaling pathway 
in zebra fish delays neuron differentiation 
and the formation of neural processes in the 
habenular nuclei (de Borsetti et al., 2011). 
This study also showed that the appropriate 
outgrowth of dendrites during habenular de-
velopment requires light and melatonin. In 
addition, some neurological diseases, includ-
ing autism can be occurred by abnormal 
melatonin synthesis (Kulman et al., 2000; 
Leu et al., 2011; Rossignol and Frye, 2011). 
It has been suggested that melatonin levels 
during early postnatal development may af-
fect the formation of brain circuits. Crupi et 
al. (2011) demonstrated a stimulatory role of 
melatonin in the adult mouse hippocampal 
neurogenesis while Ramirez-Rodriguez et al. 
(2011)  also expressed that melatonin stimu-
lated dendrite maturation in adult hippocam-
pal neurogenesis of mice. 
 
CONCLUSION 
In conclusion, this study shows that the 
stimulatory effects of melatonin on adult 
mouse SVZ proliferation are mediated 
through the melatonin receptor, which acti-
vates the ERK/MAPK signaling pathway. 
Stimulated c-Raf, ERK1/2 lead to enhance c-
Myc protein (a transcription factor) stability 
and trigger proliferative signaling. Because 
of crossing the placental and the blood-brain 
barriers and soluble in both lipids and water 
ability (Kilpatrick et al., 1995), this endoge-
nous modulator might be benefit for stimu-
lating local neural stem cell proliferation. 
The accumulated results suggest that mela-
tonin plays a trophic factor-like regulatory 
role, which provides new insights into post-
natal brain development. In addition, the dis-
covery of the mechanism by which melato-
nin modulates neural precursor cell prolifera-
tion and differentiation may be used to im-
prove innovative strategies for the therapeu-
tics of neurodegenerative diseases. 
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